Intensive care medicineHumansIntensive Care UnitsImmune Checkpoint InhibitorsNeoplasmsCritical Care
Life-threatening immune-related adverse events in the intensive care unit: a narrative review.
Samuel Pichon, Ghadi Zebian, Côme Bureau, Clémentine Levy, Charlotte Lacombe, Eve Desmedt, Pauline Wils, Emilie Merlen, Arnaud Lionet, Louis Terriou, Aurore Collet, Emmanuel Ledoult, Helene Zephir, Massih Ningarhari, Vincent Sobanski
Published: 202510.1007/s00134-025-08155-x
Abstract
BACKGROUND: Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment by significantly improving survival across various malignancies. However, they are associated with immune-related adverse events (irAEs), resulting from excessive im…
Preview only. Read the full abstract at the source